Vibrotactile Coordinated Reset for the Treatment of Advanced Parkinson's Disease

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT05504902
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Vibrotactile coordinated reset — DEVICE
    The purpose of this study is to test the efficacy of vibrotactile coordinated reset stimulation on human subject participants with Advanced stage Parkinson's disease

Study Details

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on advanced stage Parkinson's symptoms. VCR will be administered with a device called the Stanford CR Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. Patients will be followed for two years.

Key Dates

Start date
Aug 30, 2023
Status verified
Aug 2024
Primary completion
Nov 1, 2026
Completion
Nov 1, 2026

Study Design

Enrollment
35 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Vibrotactile Coordinated Reset (vCR)
    Vibrotactile Coordinated Reset delivers vibratory stimulation to the fingertips of each hand. A specific pattern of vibration to each fingertip is delivered which theoretically disrupts abnormal synchrony in the brain.

Primary Outcome Measure

Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS III) off medication [ Time Frame: Baseline, 6 months, 12 months, 18 months, 24 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford UniversityStanfordCalifornia94303-

Find similar trials in Stanford, CA

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
Stanford University· Stanford, CA

Related Studies